Products

Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding and treatment of digestive and metabolic diseases. View our comprehensive product range below.

The following pages contain comprehensive information on the Dr Falk Pharma product range. We produce four different therapies designed to treat inflammatory bowel conditions, Eosinophilic Oesophagitis and Cholestatic Liver Disease.

• Budenofalk

  

  Budenofalk (budesonide) is a topical steroid used to treat Crohn’s Disease, Microscopic Colitis and Autoimmune Hepatitis (oral formulations) and also Ulcerative Colitis (rectal formulation).

  Further Info Learn more about Liver Diseases Learn more about Inflammatory Bowel Diseases

• Salofalk

  

  Salofalk (mesalazine) is used to treat Ulcerative Colitis and is available in a range of oral and rectal formulations.

  Further Info Learn more about Inflammatory Bowel Diseases

• Ursofalk

  

  Ursofalk (ursodeoxycholic acid) is an oral medicine used to treat Primary Biliary Cholangitis (PBC), Cholesterol Gallstones, hepatobiliary disorders associated with Cystic Fibrosis. Available as capsules, tablets and suspension.

  Further Info Learn more about Liver Diseases

• Jorveza

  

  Jorveza (budesonide) is an oral treatment for the induction and maintenance of remission in patients with Eosinophilic Esophagitis (EoE) in adults.

  Further Info Learn more about Eosinophilic Esophagitis (EoE)

This information on the following pages is intended only for UK and Irish residents who have been prescribed either Budenofalk, Salofalk, Ursofalk or Jorveza.

I confirm I am a UK or Irish resident and have been prescribed either Budenofalk, Salofalk, Ursofalk or Jorveza.
I have not been prescribed any of these medications.